pop up description layer
 
 
Symposia Programme
Hall Overview
Organisation Guide
 
EASD Registration Scientific Programme
Mondial

 

Tackling Diabetes beyond the Metabolic Disorder – The power and impact of multidisciplinary approach in treating the Diabetic Foot

Monday 28th September                    14:00 – 16:30                                     Stolz.1 Hall

Chairman: Jonathan Valabhji, London, UK.

This Symposium aims to demonstrate the need for a multidisciplinary approach in treating the diabetic patient specifically in terms of reducing the number of amputations due to ischemic and neuroischemic feet . Through a series of presentations the audience will be exposed to the limits of what each specialty can achieve, given the opportunity for early intervention, when a true multi disciplinary approach is taken.

A panel of leading experts in their field will guide the audience through the role of each specialty in the treating the diabetic foot and the need for consensus in managing these patients.

14:00 – 14:20
What is the multidisciplinary team and why do we need consensus?
Jonathan Valabhji, London, UK

14:20 – 14:40
 What is the role of wound care management and what can it achieve?
Dieter Mayer, Zurich, Switzerland
14:40 – 15:00
The role of revascularization and its benefits?
Lanfroi Graziani, Brescia, Italy

15:00 – 15:20
Orthopaedic input - necessity or luxury?  
Thomas Böni, Balgrist, Switzerland

15:20 – 15:40
Infection control – the challenge of defying time!
Thomas Eberlein, Nuremberg, Germany

15:40 – 16:00
Roundtable Discussion

                      

This symposium is a joint venture between ilegx and Boston Scientific

ilegx aims to significantly reduce the number of lower limb amputations by improving the way in which leg/foot tissue loss is diagnosed and treated through an interdisciplinary collaboration which spans the acute and community services.
www.ilegx.com


Boston Scientific's mission is to improve the quality of patient care and the productivity of health care delivery through the development and advocacy of less-invasive medical devices and procedures. This is accomplished through the continuing refinement of existing products and procedures and the investigation and development of new technologies that can reduce risk, trauma, cost, procedure time and the need for aftercare.

         
 
© EASD | Contact | Imprint
ExhibitionSymposia General